AstraZeneca COVID-19 vaccine syringe with EMA official statement on risk-benefit profile for seniors - Global Banking & Finance Review
This image features a syringe filled with the AstraZeneca COVID-19 vaccine, highlighting the EMA's endorsement of its risk-benefit profile for individuals over 60. It underscores the ongoing discussions in the healthcare community regarding vaccination strategies for older adults.
Top Stories

EMA official says AstraZeneca shots have good risk-benefit profile for over 60s

Published by Wanda Rich

Posted on June 14, 2021

· Last updated: June 28, 2024

Add as preferred source on Google

Related Articles

More from Top Stories

Explore more articles in the Top Stories category